See if 68Ga-RGD PET-CT helps diagnose keloids and track treatment response

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, interventional study investigates the use of 68Ga-RGD PET-CT imaging in adults with keloids to provide diagnostic information and monitor treatment effects. The study includes Phase 1 and Phase 2 cohorts and uses 68Ga-RGD as the imaging agent to visualize fibroblast activity in keloid tissue. Outcomes focus on diagnostic evidence and changes in imaging signals as a measure of treatment response. Participants are adults with a clinical keloid diagnosis who can consent, excluding pregnant individuals, children, those with contrast media allergies, or claustrophobia. Conducted at Peking Union Medical College Hospital, the trial aims to establish whether this imaging approach adds value to current keloid management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- Patients with a clinical diagnosis of keloids Able to obtain informed consent

Exclusion Criteria:

\- Pregnant women, children, patients with allergies to contrast media Patients with claustrophobia

Where it's running

• Peking Union Medical College Hospital
  Beijing, China Recruiting

Study contacts

• Study coordinator: Zhaohui Zhu, MD
• Email: 13611093752@163.com
• Phone: 13611093752

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using ritlecitinib to treat keloids and patients undergoing keloid surgery

  This study is testing if a new medication called ritlecitinib can help treat keloids in people who have them or are having surgery to remove them.

  Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT06373458

• Radiation therapy for treating keloids

  This study is testing if radiation therapy can safely help people with stubborn keloids by reducing their size and improving their quality of life.

  Recruiting Montefiore Medical Center · The Bronx, New York · NCT04722263

• Genetic analysis of keloids

  This study is trying to find out if certain genes play a role in how keloids form and grow, by looking at saliva samples and scar tissue from people with these scars.

  Recruiting UConn Health · Farmington, Connecticut · NCT01619553

• Online survey about keloid disorder

  This study is trying to gather information from people with keloids about their experiences, family history, and treatments to better understand this condition.

  Recruiting Tirgan, Michael H., M.D. · New York, New York · NCT01423981

• Brief topical cryotherapy before steroid injections for keloid and hypertrophic scars

  This study will test whether applying a short burst of topical cryotherapy just before steroid injections lowers pain and makes injections easier for adults getting intralesional triamcinolone for keloid or hypertrophic scars.

  Recruiting Phase 3 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07336368

• Evaluating a scar gel for preventing hypertrophic scars

  This study tests a new scar gel to see if it can help prevent raised scars in people with recent scars compared to a standard product.

  Recruiting Phase 1/2 Herbarium Laboratorio Botanico Ltda · Osasco, São Paulo and 1 other locations · NCT06751433

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.